By Helgi Library - August 13, 2020
CVS Health made a net profit of USD 2,975 mil with revenues of USD 65,341 mil in 2Q2020, up by 53.7% and up by 3.01%, ...
By Helgi Library - August 13, 2020
CVS Health made a net profit of USD 2,975 mil with revenues of USD 65,341 mil in 2Q2020, up by 53.7% and up by 3.01%, ...
By Helgi Library - August 13, 2020
CVS Health's operating cash flow stood at USD 7,119 mil in 2Q2020, up 33.4% when compared to the previous year. Historic...
| Profit Statement | 2017 | 2018 | 2019 | |
| Sales | USD mil | 184,786 | 194,579 | 256,776 |
| Gross Profit | USD mil | 28,528 | 31,538 | 45,528 |
| EBITDA | USD mil | 12,017 | 6,739 | 19,028 |
| EBIT | USD mil | 9,538 | 4,021 | 11,987 |
| Financing Cost | USD mil | 1,062 | 2,619 | 3,035 |
| Pre-Tax Profit | USD mil | 8,268 | 1,406 | 8,997 |
| Net Profit | USD mil | 6,622 | -594 | 6,634 |
| Dividends | USD mil | 2,040 | 2,088 | 2,602 |
| Balance Sheet | 2017 | 2018 | 2019 | |
| Total Assets | USD mil | 95,131 | 196,456 | 222,449 |
| Non-Current Assets | USD mil | 63,902 | 151,213 | 172,147 |
| Current Assets | USD mil | 31,229 | 45,243 | 50,302 |
| Working Capital | USD mil | 19,614 | 19,946 | 19,762 |
| Shareholders' Equity | USD mil | 37,695 | 58,543 | 64,170 |
| Liabilities | USD mil | 57,436 | 137,913 | 158,279 |
| Total Debt | USD mil | 27,002 | 73,429 | 89,002 |
| Net Debt | USD mil | 25,195 | 66,848 | 80,946 |
| Ratios | 2017 | 2018 | 2019 | |
| ROE | % | 17.8 | -1.23 | 10.8 |
| ROCE | % | 7.98 | -0.466 | 3.65 |
| Gross Margin | % | 15.4 | 16.2 | 17.7 |
| EBITDA Margin | % | 6.50 | 3.46 | 7.41 |
| EBIT Margin | % | 5.16 | 2.07 | 4.67 |
| Net Margin | % | 3.58 | -0.305 | 2.58 |
| Net Debt/EBITDA | 2.10 | 9.92 | 4.25 | |
| Net Debt/Equity | % | 66.8 | 114 | 126 |
| Cost of Financing | % | 3.89 | 5.22 | 3.74 |
| Valuation | 2017 | 2018 | 2019 | |
| Market Capitalisation | USD mil | 73,515 | 84,848 | 96,726 |
| Enterprise Value (EV) | USD mil | 98,710 | 151,696 | 177,672 |
| Number Of Shares | mil | 1,024 | 1,044 | 1,305 |
| Share Price | USD | 66.6 | 61.9 | 72.6 |
| EV/EBITDA | 8.21 | 22.5 | 9.34 | |
| EV/Sales | 0.534 | 0.780 | 0.692 | |
| Price/Earnings (P/E) | 10.3 | -109 | 14.3 | |
| Price/Book Value (P/BV) | 1.81 | 1.10 | 1.48 | |
| Dividend Yield | % | 3.00 | 3.23 | 2.75 |
Get all company financials in excel:
| overview | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| income statement | ||||||||||||||||||||||||||||
| Sales | USD mil | ... | ... | ... | ... | ... | ... | ... | 126,761 | 139,367 | 153,290 | 177,546 | 184,786 | |||||||||||||||
| Gross Profit | USD mil | ... | ... | ... | ... | ... | ... | ... | 23,783 | 25,367 | 26,528 | 28,834 | 28,528 | |||||||||||||||
| EBIT | USD mil | ... | ... | ... | ... | ... | ... | ... | 8,037 | 8,799 | 9,475 | 10,386 | 9,538 | |||||||||||||||
| Net Profit | USD mil | ... | ... | ... | ... | ... | ... | ... | 4,592 | 4,644 | 5,237 | 5,317 | 6,622 | |||||||||||||||
| ROE | % | ... | ... | ... | ... | ... | ... | ... | ... | 12.1 | 12.2 | 13.9 | 14.4 | 17.8 | ||||||||||||||
| EBIT Margin | % | ... | ... | ... | ... | ... | ... | ... | 6.34 | 6.31 | 6.18 | 5.85 | 5.16 | |||||||||||||||
| Net Margin | % | ... | ... | ... | ... | ... | ... | ... | 3.62 | 3.33 | 3.42 | 2.99 | 3.58 | |||||||||||||||
| Employees | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 137,800 | 155,000 | 158,000 | 160,000 | |||||||||||||
| balance sheet | ||||||||||||||||||||||||||||
| Total Assets | USD mil | ... | ... | ... | ... | ... | ... | ... | 71,526 | 74,187 | 92,437 | 94,462 | 95,131 | |||||||||||||||
| Non-Current Assets | USD mil | ... | ... | ... | ... | ... | ... | ... | 46,201 | 48,204 | 63,279 | 63,420 | 63,902 | |||||||||||||||
| Current Assets | USD mil | ... | ... | ... | ... | ... | ... | ... | 25,325 | 25,983 | 29,158 | 31,042 | 31,229 | |||||||||||||||
| Shareholders' Equity | USD mil | ... | ... | ... | ... | ... | ... | ... | 37,938 | 37,963 | 37,242 | 36,834 | 37,695 | |||||||||||||||
| Liabilities | USD mil | ... | ... | ... | ... | ... | ... | ... | 33,588 | 36,224 | 55,195 | 57,628 | 57,436 | |||||||||||||||
| Non-Current Liabilities | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Current Liabilities | USD mil | ... | ... | ... | ... | ... | ... | ... | 15,425 | 19,027 | 23,169 | 26,250 | 30,648 | |||||||||||||||
| Net Debt/EBITDA | ... | ... | ... | ... | ... | ... | ... | 0.931 | 0.967 | 2.15 | 1.87 | 2.10 | ||||||||||||||||
| Net Debt/Equity | % | ... | ... | ... | ... | ... | ... | ... | 24.3 | 27.3 | 66.9 | 65.4 | 66.8 | |||||||||||||||
| Cost of Financing | % | ... | ... | ... | ... | ... | ... | ... | ... | 4.45 | 4.68 | 4.26 | 3.92 | 3.89 | ||||||||||||||
| cash flow | ||||||||||||||||||||||||||||
| Total Cash From Operations | USD mil | ... | ... | ... | ... | ... | ... | ... | 5,783 | 8,137 | 8,539 | 10,141 | 8,007 | |||||||||||||||
| Total Cash From Investing | USD mil | ... | ... | ... | ... | ... | ... | ... | -1,835 | -4,045 | -13,420 | -2,470 | -2,877 | |||||||||||||||
| Total Cash From Financing | USD mil | ... | ... | ... | ... | ... | ... | ... | -1,237 | -5,694 | 4,879 | -6,761 | -6,751 | |||||||||||||||
| Net Change In Cash | USD mil | ... | ... | ... | ... | ... | ... | ... | 2,714 | -1,608 | -22.0 | 912 | -1,620 | |||||||||||||||
| valuation | ||||||||||||||||||||||||||||
| Market Capitalisation | USD mil | 84,453 | 109,793 | 107,645 | 83,724 | 73,515 | ||||||||||||||||||||||
| Enterprise Value (EV) | USD mil | ... | ... | ... | ... | ... | ... | ... | 93,678 | 120,168 | 132,562 | 107,797 | 98,710 | |||||||||||||||
| Number Of Shares | mil | 1,226 | 1,169 | 1,126 | 1,079 | 1,024 | ||||||||||||||||||||||
| Share Price | USD | 61.2 | 83.6 | 86.0 | 70.7 | 66.6 | ||||||||||||||||||||||
| Price/Earnings (P/E) | ... | 16.4 | 21.1 | 18.6 | 14.4 | 10.3 | ||||||||||||||||||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 12.5 | 16.2 | 14.4 | 10.9 | 8.20 | ||||||||
| EV/EBITDA | ... | ... | ... | ... | ... | ... | ... | 9.46 | 11.2 | 11.5 | 8.38 | 8.21 | ||||||||||||||||
| Price/Book Value (P/BV) | ... | ... | ... | ... | ... | ... | ... | 1.98 | 2.57 | 2.60 | 2.07 | 1.81 | ||||||||||||||||
| Dividend Yield | % | 1.47 | 1.32 | 1.63 | 2.41 | 3.00 |
| income statement | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| income statement | ||||||||||||||||||||||||||||
| Sales | USD mil | ... | ... | ... | ... | ... | ... | ... | 126,761 | 139,367 | 153,290 | 177,546 | 184,786 | |||||||||||||||
| Cost of Goods & Services | USD mil | ... | ... | ... | ... | ... | ... | ... | 102,978 | 114,000 | 126,762 | 148,712 | 156,258 | |||||||||||||||
| Gross Profit | USD mil | ... | ... | ... | ... | ... | ... | ... | 23,783 | 25,367 | 26,528 | 28,834 | 28,528 | |||||||||||||||
| Selling, General & Admin | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
| Research & Development | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||
| Other Operating Expense | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 15,746 | 16,568 | 17,053 | 18,448 | 18,760 | ||||||
| Other Operating Cost (Income) | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ||||||
| EBITDA | USD mil | ... | ... | ... | ... | ... | ... | ... | 9,907 | 10,730 | 11,567 | 12,861 | 12,017 | |||||||||||||||
| Depreciation | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 1,400 | 1,400 | 1,481 | 1,700 | 1,700 | |||||||
| EBIT | USD mil | ... | ... | ... | ... | ... | ... | ... | 8,037 | 8,799 | 9,475 | 10,386 | 9,538 | |||||||||||||||
| Net Financing Cost | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 509 | 600 | 838 | 1,078 | 1,062 | |||||||||||
| Financing Cost | USD mil | ... | ... | ... | ... | ... | ... | ... | 517 | 615 | 859 | 1,078 | 1,062 | |||||||||||||||
| Financing Income | USD mil | ... | ... | ... | ... | ... | ... | ... | 8.00 | 15.0 | 21.0 | 0 | 0 | |||||||||||||||
| FX (Gain) Loss | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
| Extraordinary Cost | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | 8.00 | 1.00 | -9.00 | 1.00 | 8.00 | ||||||||||||||
| Pre-Tax Profit | USD mil | ... | ... | ... | ... | ... | ... | ... | 7,528 | 7,678 | 8,616 | 8,637 | 8,268 | |||||||||||||||
| Tax | USD mil | ... | ... | ... | ... | ... | ... | ... | 2,928 | 3,033 | 3,386 | 3,317 | 1,637 | |||||||||||||||
| Minorities | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 2.00 | 2.00 | 1.00 | ||||||||||||||
| Net Profit | USD mil | ... | ... | ... | ... | ... | ... | ... | 4,592 | 4,644 | 5,237 | 5,317 | 6,622 | |||||||||||||||
| Net Profit Avail. to Common | USD mil | ... | ... | ... | ... | ... | ... | ... | 4,592 | 4,625 | 5,210 | 5,317 | 6,622 | |||||||||||||||
| Dividends | USD mil | ... | ... | ... | ... | ... | ... | ... | 1,095 | 1,277 | 1,565 | 1,824 | 2,040 | |||||||||||||||
| growth rates | ||||||||||||||||||||||||||||
| Total Revenue Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 2.96 | 9.94 | 9.99 | 15.8 | 4.08 | ||||||||||||||
| Operating Cost Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 3.06 | 5.22 | 2.93 | 8.18 | 2.94 | ||||||||||||||
| EBITDA Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 10.5 | 8.31 | 7.80 | 11.2 | -6.56 | ||||||||||||||
| EBIT Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 11.5 | 9.48 | 7.68 | 9.61 | -8.16 | ||||||||||||||
| Pre-Tax Profit Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 19.4 | 1.99 | 12.2 | 0.244 | -4.27 | ||||||||||||||
| Net Profit Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 18.8 | 0.719 | 12.6 | 2.05 | 24.5 | ||||||||||||||
| ratios | ||||||||||||||||||||||||||||
| ROE | % | ... | ... | ... | ... | ... | ... | ... | ... | 12.1 | 12.2 | 13.9 | 14.4 | 17.8 | ||||||||||||||
| ROA | % | ... | ... | ... | ... | ... | ... | ... | ... | 6.67 | 6.37 | 6.29 | 5.69 | 6.99 | ||||||||||||||
| ROCE | % | ... | ... | ... | ... | ... | ... | ... | ... | 7.72 | 7.51 | 7.23 | 6.48 | 7.98 | ||||||||||||||
| Gross Margin | % | ... | ... | ... | ... | ... | ... | ... | 18.8 | 18.2 | 17.3 | 16.2 | 15.4 | |||||||||||||||
| EBITDA Margin | % | ... | ... | ... | ... | ... | ... | ... | 7.82 | 7.70 | 7.55 | 7.24 | 6.50 | |||||||||||||||
| EBIT Margin | % | ... | ... | ... | ... | ... | ... | ... | 6.34 | 6.31 | 6.18 | 5.85 | 5.16 | |||||||||||||||
| Net Margin | % | ... | ... | ... | ... | ... | ... | ... | 3.62 | 3.33 | 3.42 | 2.99 | 3.58 | |||||||||||||||
| Payout Ratio | % | ... | ... | ... | ... | ... | ... | ... | 23.9 | 27.5 | 29.9 | 34.3 | 30.8 | |||||||||||||||
| Cost of Financing | % | ... | ... | ... | ... | ... | ... | ... | ... | 4.45 | 4.68 | 4.26 | 3.92 | 3.89 | ||||||||||||||
| Net Debt/EBITDA | ... | ... | ... | ... | ... | ... | ... | 0.931 | 0.967 | 2.15 | 1.87 | 2.10 |
| balance sheet | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| balance sheet | ||||||||||||||||||||||||||||
| Cash & Cash Equivalents | USD mil | ... | ... | ... | ... | ... | ... | ... | 4,177 | 2,515 | 2,547 | 3,458 | 1,807 | |||||||||||||||
| Receivables | USD mil | ... | ... | ... | ... | ... | ... | ... | 8,729 | 9,687 | 11,888 | 12,164 | 13,181 | |||||||||||||||
| Inventories | USD mil | ... | ... | ... | ... | ... | ... | ... | 11,045 | 11,930 | 14,001 | 14,760 | 15,296 | |||||||||||||||
| Other ST Assets | USD mil | ... | ... | ... | ... | ... | ... | ... | 1,374 | 1,851 | 722 | 660 | 945 | |||||||||||||||
| Current Assets | USD mil | ... | ... | ... | ... | ... | ... | ... | 25,325 | 25,983 | 29,158 | 31,042 | 31,229 | |||||||||||||||
| Property, Plant & Equipment | USD mil | ... | ... | ... | ... | ... | ... | ... | 8,615 | 8,843 | 9,855 | 10,175 | 10,292 | |||||||||||||||
| LT Investments & Receivables | USD mil | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
| Intangible Assets | USD mil | ... | ... | ... | ... | ... | ... | ... | 36,071 | 37,916 | 51,984 | 51,760 | 52,081 | |||||||||||||||
| Goodwill | USD mil | ... | ... | ... | ... | ... | ... | ... | 26,542 | 28,142 | 38,106 | 38,249 | 38,451 | |||||||||||||||
| Non-Current Assets | USD mil | ... | ... | ... | ... | ... | ... | ... | 46,201 | 48,204 | 63,279 | 63,420 | 63,902 | |||||||||||||||
| Total Assets | USD mil | ... | ... | ... | ... | ... | ... | ... | 71,526 | 74,187 | 92,437 | 94,462 | 95,131 | |||||||||||||||
| Trade Payables | USD mil | ... | ... | ... | ... | ... | ... | ... | 5,548 | 6,547 | 7,490 | 7,946 | 8,863 | |||||||||||||||
| Short-Term Debt | USD mil | ... | ... | ... | ... | ... | ... | ... | 561 | 1,260 | 1,197 | 1,916 | 4,821 | |||||||||||||||
| Other ST Liabilities | USD mil | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 23.0 | |||||||||||||||
| Current Liabilities | USD mil | ... | ... | ... | ... | ... | ... | ... | 15,425 | 19,027 | 23,169 | 26,250 | 30,648 | |||||||||||||||
| Long-Term Debt | USD mil | ... | ... | ... | ... | ... | ... | ... | 12,841 | 11,630 | 26,267 | 25,615 | 22,181 | |||||||||||||||
| Other LT Liabilities | USD mil | ... | ... | ... | ... | ... | ... | ... | 5,322 | 5,567 | 5,759 | 5,763 | 4,607 | |||||||||||||||
| Non-Current Liabilities | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Liabilities | USD mil | ... | ... | ... | ... | ... | ... | ... | 33,588 | 36,224 | 55,195 | 57,628 | 57,436 | |||||||||||||||
| Preferred Equity and Hybrid Capital | USD mil | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
| Share Capital | USD mil | ... | ... | ... | ... | ... | ... | ... | 29,794 | 30,435 | 30,965 | 31,635 | 32,096 | |||||||||||||||
| Treasury Stock | USD mil | ... | ... | ... | ... | ... | ... | ... | 20,169 | 24,078 | 28,886 | 33,452 | 37,765 | |||||||||||||||
| Equity Before Minority Interest | USD mil | ... | ... | ... | ... | ... | ... | ... | 37,938 | 37,958 | 37,196 | 36,830 | 37,691 | |||||||||||||||
| Minority Interest | USD mil | ... | ... | ... | ... | ... | ... | ... | 0 | 5.00 | 46.0 | 4.00 | 4.00 | |||||||||||||||
| Equity | USD mil | ... | ... | ... | ... | ... | ... | ... | 37,938 | 37,963 | 37,242 | 36,834 | 37,695 | |||||||||||||||
| growth rates | ||||||||||||||||||||||||||||
| Total Asset Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 8.01 | 3.72 | 24.6 | 2.19 | 0.708 | ||||||||||||||
| Shareholders' Equity Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 0.757 | 0.066 | -1.90 | -1.10 | 2.34 | ||||||||||||||
| Net Debt Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 9.20 | 12.5 | 140 | -3.39 | 4.66 | ||||||||||||||
| Total Debt Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 36.4 | -3.82 | 113 | 0.244 | -1.92 | ||||||||||||||
| ratios | ||||||||||||||||||||||||||||
| Total Debt | USD mil | ... | ... | ... | ... | ... | ... | ... | 13,402 | 12,890 | 27,464 | 27,531 | 27,002 | |||||||||||||||
| Net Debt | USD mil | ... | ... | ... | ... | ... | ... | ... | 9,225 | 10,375 | 24,917 | 24,073 | 25,195 | |||||||||||||||
| Working Capital | USD mil | ... | ... | ... | ... | ... | ... | ... | 14,226 | 15,070 | 18,399 | 18,978 | 19,614 | |||||||||||||||
| Capital Employed | USD mil | ... | ... | ... | ... | ... | ... | ... | 60,427 | 63,274 | 81,678 | 82,398 | 83,516 | |||||||||||||||
| Net Debt/Equity | % | ... | ... | ... | ... | ... | ... | ... | 24.3 | 27.3 | 66.9 | 65.4 | 66.8 | |||||||||||||||
| Current Ratio | ... | ... | ... | ... | ... | ... | ... | 1.64 | 1.37 | 1.26 | 1.18 | 1.02 | ||||||||||||||||
| Quick Ratio | ... | ... | ... | ... | ... | ... | ... | 0.837 | 0.641 | 0.623 | 0.595 | 0.489 |
| cash flow | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| cash flow | ||||||||||||||||||||||||||||
| Net Profit | USD mil | ... | ... | ... | ... | ... | ... | ... | 4,592 | 4,644 | 5,237 | 5,317 | 6,622 | |||||||||||||||
| Depreciation | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 1,400 | 1,400 | 1,481 | 1,700 | 1,700 | |||||||
| Non-Cash Items | USD mil | ... | ... | ... | ... | ... | ... | ... | -81.0 | 650 | -136 | 1,164 | -1,349 | |||||||||||||||
| Change in Working Capital | USD mil | ... | ... | ... | ... | ... | ... | ... | -598 | 912 | 1,346 | 1,185 | 255 | |||||||||||||||
| Total Cash From Operations | USD mil | ... | ... | ... | ... | ... | ... | ... | 5,783 | 8,137 | 8,539 | 10,141 | 8,007 | |||||||||||||||
| Capital Expenditures | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -1,930 | -2,125 | -2,332 | -2,224 | -1,918 | ||||||
| Net Change in LT Investment | USD mil | ... | ... | ... | ... | ... | ... | ... | 600 | 515 | 411 | 230 | 265 | |||||||||||||||
| Net Cash From Acquisitions | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -415 | -2,439 | -11,475 | -524 | -1,181 | ||||||
| Other Investing Activities | USD mil | ... | ... | ... | ... | ... | ... | ... | -90.0 | 4.00 | -24.0 | 48.0 | -43.0 | |||||||||||||||
| Total Cash From Investing | USD mil | ... | ... | ... | ... | ... | ... | ... | -1,835 | -4,045 | -13,420 | -2,470 | -2,877 | |||||||||||||||
| Dividends Paid | USD mil | ... | ... | ... | ... | ... | ... | ... | -1,097 | -1,288 | -1,576 | -1,840 | -2,049 | |||||||||||||||
| Issuance Of Shares | USD mil | ... | ... | ... | ... | ... | ... | ... | -3,414 | -3,474 | -4,639 | -4,165 | -4,032 | |||||||||||||||
| Issuance Of Debt | USD mil | ... | ... | ... | ... | ... | ... | ... | 3,274 | -932 | 11,218 | -614 | -598 | |||||||||||||||
| Other Financing Activities | USD mil | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | -124 | -142 | -72.0 | |||||||||||||||
| Total Cash From Financing | USD mil | ... | ... | ... | ... | ... | ... | ... | -1,237 | -5,694 | 4,879 | -6,761 | -6,751 | |||||||||||||||
| Effect of FX Rates | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 3.00 | -6.00 | -20.0 | 2.00 | 1.00 | ||||||
| Net Change In Cash | USD mil | ... | ... | ... | ... | ... | ... | ... | 2,714 | -1,608 | -22.0 | 912 | -1,620 | |||||||||||||||
| ratios | ||||||||||||||||||||||||||||
| Days Sales Outstanding | days | ... | ... | ... | ... | ... | ... | ... | 25.1 | 25.4 | 28.3 | 25.0 | 26.0 | |||||||||||||||
| Days Sales Of Inventory | days | ... | ... | ... | ... | ... | ... | ... | 39.1 | 38.2 | 40.3 | 36.2 | 35.7 | |||||||||||||||
| Days Payable Outstanding | days | ... | ... | ... | ... | ... | ... | ... | 19.7 | 21.0 | 21.6 | 19.5 | 20.7 | |||||||||||||||
| Cash Conversion Cycle | days | ... | ... | ... | ... | ... | ... | ... | 44.6 | 42.6 | 47.1 | 41.7 | 41.1 | |||||||||||||||
| Cash Earnings | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 5,992 | 6,044 | 6,718 | 7,017 | 8,322 | |||||||
| Free Cash Flow | USD mil | ... | ... | ... | ... | ... | ... | ... | 3,948 | 4,092 | -4,881 | 7,671 | 5,130 | |||||||||||||||
| Capital Expenditures (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | 1.52 | 1.52 | 1.52 | 1.25 | 1.04 |
| other ratios | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Employees | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 137,800 | 155,000 | 158,000 | 160,000 | |||||||||||||
| Women (As % of Workforce) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 67.0 | 67.0 | 68.0 | 68.0 | 68.0 | ||||||||
| Women (As % of Management) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
| Operating Cost (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | 12.4 | 11.9 | 11.1 | 10.4 | 10.3 | |||||||||||||||
| Research & Development (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||
| Effective Tax Rate | % | ... | ... | ... | ... | ... | ... | ... | 38.9 | 39.5 | 39.3 | 38.4 | 19.8 | |||||||||||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 7.70 | 7.25 | 9.86 | 10.6 | 8.46 | ||||||||||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 16.9 | 16.4 | 15.3 | 15.0 | 9.24 |
| valuation | Unit | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Market Capitalisation | USD mil | 84,453 | 109,793 | 107,645 | 83,724 | 73,515 | ||||||||||||||||||||||
| Enterprise Value (EV) | USD mil | ... | ... | ... | ... | ... | ... | ... | 93,678 | 120,168 | 132,562 | 107,797 | 98,710 | |||||||||||||||
| Number Of Shares | mil | 1,226 | 1,169 | 1,126 | 1,079 | 1,024 | ||||||||||||||||||||||
| Share Price | USD | 61.2 | 83.6 | 86.0 | 70.7 | 66.6 | ||||||||||||||||||||||
| EV/EBITDA | ... | ... | ... | ... | ... | ... | ... | 9.46 | 11.2 | 11.5 | 8.38 | 8.21 | ||||||||||||||||
| Price/Earnings (P/E) | ... | 16.4 | 21.1 | 18.6 | 14.4 | 10.3 | ||||||||||||||||||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 12.5 | 16.2 | 14.4 | 10.9 | 8.20 | ||||||||
| P/FCF | ... | ... | ... | ... | ... | ... | ... | 19.0 | 23.9 | -19.8 | 9.94 | 13.3 | ||||||||||||||||
| Price/Book Value (P/BV) | ... | ... | ... | ... | ... | ... | ... | 1.98 | 2.57 | 2.60 | 2.07 | 1.81 | ||||||||||||||||
| Dividend Yield | % | 1.47 | 1.32 | 1.63 | 2.41 | 3.00 | ||||||||||||||||||||||
| Free Cash Flow Yield | % | ... | ... | ... | ... | ... | ... | ... | 4.67 | 3.73 | -4.53 | 9.16 | 6.98 | |||||||||||||||
| Earnings Per Share (EPS) | USD | ... | 3.74 | 3.96 | 4.63 | 4.90 | 6.44 | |||||||||||||||||||||
| Cash Earnings Per Share | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 4.89 | 5.17 | 5.97 | 6.50 | 8.13 | |||||||
| Free Cash Flow Per Share | USD | ... | ... | ... | ... | ... | ... | ... | 3.22 | 3.50 | -4.33 | 7.11 | 5.01 | |||||||||||||||
| Book Value Per Share | USD | ... | ... | ... | ... | ... | ... | ... | 30.9 | 32.5 | 33.1 | 34.1 | 36.8 | |||||||||||||||
| Dividend Per Share | USD | 0.900 | 1.10 | 1.40 | 1.70 | 2.00 | ||||||||||||||||||||||
| EV/Sales | ... | ... | ... | ... | ... | ... | ... | 0.739 | 0.862 | 0.865 | 0.607 | 0.534 | ||||||||||||||||
| EV/EBIT | ... | ... | ... | ... | ... | ... | ... | 11.7 | 13.7 | 14.0 | 10.4 | 10.3 | ||||||||||||||||
| EV/Free Cash Flow | ... | ... | ... | ... | ... | ... | ... | 23.7 | 29.4 | -27.2 | 14.1 | 19.2 | ||||||||||||||||
| EV/Capital Employed | ... | ... | ... | ... | ... | ... | ... | 1.55 | 1.90 | 1.62 | 1.31 | 1.18 | ||||||||||||||||
| Earnings Per Share Growth | % | ... | ... | ... | 23.8 | 5.88 | 16.9 | 5.83 | 31.4 | |||||||||||||||||||
| Cash Earnings Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 21.1 | 5.79 | 15.4 | 9.00 | 25.0 | ||||
| Book Value Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 5.19 | 4.95 | 1.85 | 3.21 | 7.83 |
Get all company financials in excel:
By Helgi Library - August 13, 2020
CVS Health's operating cash flow stood at USD 7,119 mil in 2Q2020, up 33.4% when compared to the previous year. Historically, between 1Q2010 - 2Q2020, the firm’s operating cash flow reached a high of USD 7,119 mil in 2Q2020 and a low of USD -136 mil ...
By Helgi Library - October 12, 2020
CVS Health's total assets reached USD 235,495 mil at the end of 2Q2020, up 7.58% compared to the previous year. Current assets amounted to USD 62,506 mil, or 26.5% of total assets while cash stood at USD 17,465 mil at the end of 2Q2020. ...
By Helgi Library - October 12, 2020
CVS Health's total assets reached USD 235,495 mil at the end of 2Q2020, up 7.58% compared to the previous year. Current assets amounted to USD 62,506 mil, or 26.5% of total assets while cash stood at USD 17,465 mil at the end of 2Q2020. ...
By Helgi Library - August 13, 2020
CVS Health made a net profit of USD 6,634 mil in 2019, up 1% compared to the previous year. Total sales reached USD 256,776 mil, which is up 32% when compared to the previous year. Historically, between 2000 and 2019, the company’s net profit reach...
By Helgi Library - August 13, 2020
CVS Health made a net profit of USD 6,634 mil in 2019, up 1% compared to the previous year. Total sales reached USD 256,776 mil, which is up 32% when compared to the previous year. Historically, between 2000 and 2019, the company’s net profit reach...
By Helgi Library - August 13, 2020
CVS Health stock traded at USD 72.6 per share at the end 2019 translating into a market capitalization of USD 96,726 mil. Since the end of 2014, stock has depreciated by 13.1% representing an annual average growth of -2.78%. In absolute terms, the value...
By Helgi Library - August 13, 2020
CVS Health stock traded at USD 72.6 per share at the end 2019 translating into a market capitalization of USD 96,726 mil. Since the end of 2014, stock has depreciated by 13.1% representing an annual average growth of -2.78%. In absolute terms, the value...
By Helgi Library - August 13, 2020
CVS Health stock traded at USD 72.6 per share at the end 2019 implying a market capitalization of USD 96,726 mil. Since the end of 2014, stock has appreciated by -13.1% implying an annual average growth of -2.78% In absolute terms, the value of the company ...
By Helgi Library - August 13, 2020
CVS Health invested a total of USD 2,457 mil in 2019, up 20.6% compared to the previous year. Historically, between 2009 - 2019, the company's investments stood at a high of USD 2,525 mil in 2009 and a low of USD 1,868 mil in 2011. As...
By Helgi Library - August 13, 2020
CVS Health made a net profit of USD 6,634 mil in 2019, up 1% compared to the previous year. Historically, between 2000 and 2019, the company's net profit reached a high of USD 6,634 mil in 2019 and a low of USD -594 mil in 2018. The result implies a retur...
CVS Health Corporation is an integrated pharmacy health care provider. The Company's offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico. Company’s retail segment sells prescription and over-the-counter drugs, beauty and personal care products, and cosmetics; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. At the end of 2019, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies
CVS Health has been growing its sales by 13.0% a year on average in the last 5 years. EBITDA has grown on average by 12.1% a year during that time to total of USD 19,028 mil in 2019, or 7.41% of sales. That’s compared to 6.43% average margin seen in last five years.
The company netted USD 6,634 mil in 2019 implying ROE of 10.8% and ROCE of 3.65%. Again, the average figures were 11.1% and 4.98%, respectively when looking at the previous 5 years.
CVS Health’s net debt amounted to USD 80,946 mil at the end of 2019, or 126% of equity. When compared to EBITDA, net debt was 4.25x, up when compared to average of 4.06x seen in the last 5 years.
CVS Health stock traded at USD 72.6 per share at the end of 2019 resulting in a market capitalization of USD 96,726 mil. Over the previous five years, stock price fell by 13.1% or -2.78% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 9.34x and price to earnings (PE) of 14.3x as of 2019.
Helgi Library 
